Let’s learn from our neighbors from the North as we get the menthol flavor out of cigarettes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the trenches on the medicine wards and smoking cessation clinics at Parkland Hospital  and UT Southwestern Simmons Cancer Center, I see firsthand the increased prevalence of smoking in the Black population, their frequent use of menthol, and the ravaging toll it takes on their health.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
David Balis, MD
Director, Smoking Cessation Clinics, Parkland Hospital, UT Southwestern Simmons Cancer Center; Professor, General Internal Medicine, UT Southwestern
Table of Contents

YOU MAY BE INTERESTED IN

FDA granted full approval for Vitrakvi (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment. 
David Balis, MD
Director, Smoking Cessation Clinics, Parkland Hospital, UT Southwestern Simmons Cancer Center; Professor, General Internal Medicine, UT Southwestern

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login